Increase text size: A A A

Type in the condition you need,
or visit Advanced Search

Print this page

Email this to a friend

Comment on this page

Save to my Health Library

Johns Hopkins Health Alert

Aggressive Treatment Pays Off

For patients with advanced, metastatic colorectal cancer that has spread to the liver, surgery offers hope, according to a study in the Annals of Surgical Oncology.

The treatments for advanced cancer are much the same as for newly diagnosed cancer. However, they are more aggressive. They include:

  • Surgery to remove cancer where it has returned or metastasized. This could be localized or could involve extensive surgery for metastases in the liver or other organs.
  • Radiation and/or chemotherapy to control and contain the cancer, especially if it is inoperable.
  • Other techniques could involve freezing tumors (cryosurgery), burning them away with microwaves, or other methods of treating a well-defined area where a cancer is present.

Surgery for colorectal cancer that has spread to the liver results in good long-term survival rates, even for patients who have more than one metastasized tumor, according to a Canadian study reported in the Annals of Surgical Oncology (Volume 13, page 668).

Researchers reviewed the results of liver surgeries for metastatic colorectal cancer in 423 operations over a 10-year period at one cancer center, looking at the death rate from surgery, disease-free survival, and overall survival. More than half of the operations (65%) were major, involving more than four segments of the liver.

Overall, death and illness due to the operation were fairly rare: Seven patients died (1.6%) and 74 (17%) were sicker in connection with the surgery. In contrast, the disease-free survival rate at one year was 64%; at five years, 27%; and at 10 years post surgery, 22%. The overall and long-term survival rates were even better: 93%, 47%, and 28%, respectively.

Factors that predicted less successful outcomes included older age (patients over 60); surgical margins that tested positive for malignant cells; large metastatic tumors; and many metastases. However, researchers concluded that the overall good survival rates justify taking an aggressive surgical approach, even for patients with many metastases.

Posted in Colon Cancer on May 13, 2008
Reviewed July 2009

Comments

Post a Comment

Health Alerts registered users may post comments and share experiences here at their own discretion. We regret that questions on individual health concerns to the Johns Hopkins editors cannot be answered in this space.

The views expressed here do not constitute medical advice, and do not represent the position of Johns Hopkins Medicine or MediZine LLC, which has no responsibility for any comments posted on this site.




Post a Comment


Already a subscriber?
Login

Email:

Password:


Forgot your password?

New to Johns Hopkins Health Alerts?
Register to submit your comments.

Your Email Address:

(example: yourname@domain.com)

 

(800) 829-0422

Registered Users Log-in:

Email:

Password:

Remember me
Forgot Password?

Become a Registered User!
It's fast and FREE!
The Benefits of Being A Registered User

Health Topic Pages

Arthritis
Back Pain & Osteoporosis
Cancer
Caregivers | Caregiving
Colon Cancer
Complementary Medicine
Depression & Anxiety
Diabetes
Digestive Health
Enlarged Prostate
Exercise and Fitness
Healthy Living
Heart Health
Hypertension & Stroke
Lung Disorders
Memory
Men's Health
Nutrition
Prescription Drugs
Prostate Disorders
Sexual Health
Vision
Weight Control
Women's Health
Health Alert Special Report


COME SEE WHAT'S NEW IN THE BOOKSTORE!


ALL NEW!Number One of America's Best Hospitals 2009: Johns Hopkins

The Johns Hopkins Hospital has been ranked #1 again in the Honor Roll of America's Best Hospitals by
U.S. News and World Report for the 19th consecutive year.


Please visit here for more information about Johns Hopkins Patient Services


© 2010 MediZine LLC. All rights reserved.
Contact Us
customerservice@johnshopkinshealthalerts.com